Evaluation of lyophilized human amnion/chorion membrane (LHACM) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPAIGN trial
International Journal of Tissue Repair · 2025
DOI: 10.63676/tk3kw419 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Tissue Repair, 2025. Verfasst von Thomas E Serena und 3 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Background
Diabetic foot ulcers (DFUs) are chronic wounds that contribute significantly to morbidity, mortality, and healthcare costs. Despite current standard-of-care (SOC) approaches, healing rates re-main suboptimal, emphasizing the urgent need for innovative and cost-effective treatment options.
Methods
An interim analysis of this multicenter, prospective, randomized controlled platform clinical trial evaluated the efficacy of multiple lyophilized human amnion/chorion membrane (LHACMs) with SOC versus SOC alone. The primary endpoint was percentage of target ulcers achieving complete wound closure in 12 weeks, defined as 100% re-epithelialization without drainage for two consecutive weeks, confirmed by blinded independent review.
Results
The statistical analysis revealed that the treatment arm improved full wound closure at 12 weeks over SOC by 2.6 (credible interval: 0.81 – 5.0) in terms of relative. The estimated probability of complete wound closure under SOC was 23% (6.5%–42%), compared with 47% (37%–59%) under the treatment arm. This corresponds to a posterior absolute difference of 24% (4%–43%). This suggests a posterior probability advantage of 98.5% for LHACM.
Conclusion
The interim analysis revealed that the placental membranes products trended to-ward superiority over SOC. Bayesian posterior estimates indicated 98.5% higher probabilities of wound closure and improved healing trajectories in the treatment group. These interim data provide early evidence of clinical benefit, subject to confirmation with full trial completion.
Zitieren
APA
Serena, T. E., Tramelli, B., Bonafide, B., & Tunyiswa, Z. (2025). Evaluation of lyophilized human amnion/chorion membrane (LHACM) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPAIGN trial. International Journal of Tissue Repair. https://doi.org/10.63676/tk3kw419
Vancouver
Serena TE, Tramelli B, Bonafide B, Tunyiswa Z. Evaluation of lyophilized human amnion/chorion membrane (LHACM) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPAIGN trial. International Journal of Tissue Repair. 2025. doi:10.63676/tk3kw419
BibTeX
@article{Serena2025,
author = {Serena, Thomas E and Tramelli, Brianna and Bonafide, Brittany and Tunyiswa, Zwelithini},
title = {Evaluation of lyophilized human amnion/chorion membrane (LHACM) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPAIGN trial},
journal = {International Journal of Tissue Repair},
year = {2025},
doi = {10.63676/tk3kw419}
}
EUVIMED